Loading organizations...
Loading organizations...
Biotech company focused on gene editing and breakthrough therapies.
Positive Sequence Biology has raised $19.5M across 2 funding rounds.
Positive Sequence Biology has raised $19.5M in total across 2 funding rounds.
Positive Sequence Biology has raised $19.5M in total across 2 funding rounds.
Positive Sequence Biology's investors include Zoo Capital.
Positive Sequence Biology has raised $19.5M across 2 funding rounds. Most recently, it raised $13.9M Series A in August 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 8, 2024 | $13.9M Series A | ||
| Jun 13, 2023 | $5.6M Other Equity | Zoo Capital |